Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with malignancies in humans. Viral infection of B cells is initiated by the viral glycoprotein 350 (gp350) binding to complement receptor 2 (CR2). Despite decades of effort, no vaccines or curative agents have been developed, partly due to lack of atomic-level understanding of the virus-host interface. Here, we determined the 1.7 Å structure of gp350 in complex with CR2. CR2 binding of gp350 utilized the same set of Arg residues required for recognition of its natural ligand, complement C3d. We further determined the structures of gp350 in complex with three potently neutralizing antibodies (nAbs) obtained from vaccinated macaques and EBV-infected individuals. Like the CR2 interaction, these nAbs targeted the acidic pocket within the CR2-binding site on gp350 using Arg residues. Our results illustrate two axes of molecular mimicry-gp350 versus C3d and CR2 versus EBV nAbs-offering insights for EBV vaccines and therapeutics development.

Authors

Institutions

Publication Details

Journal
Immunity
Published
2025-02-01
DOI
https://doi.org/10.1016/j.immuni.2025.01.010
Citations
8
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
10.83

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

Adrian B. McDermott, Adam K. Wheatley, Jaime L. Jensen, Jeffrey I. Cohen et al.
8 citations
Immunity
Cytomegalovirus and herpesvirus research
10.83
article

Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

Adrian B. McDermott, Adam K. Wheatley, Jaime L. Jensen, Jeffrey I. Cohen, Peter D. Kwong, Sarah F. Andrews, Tyler Stephens, Masaru Kanekiyo, Sandeep Narpala, Gary J. Nabel, Yaroslav Tsybovsky, Wei Bu, John R. Mascola, Rebecca A. Gillespie, Madhu Prabhakaran, Wei‐Hung Chen, Brian E. Fisher, M. Gordon Joyce, Meghna Bagchi
article en
8 citations

Abstract

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with malignancies in humans. Viral infection of B cells is initiated by the viral glycoprotein 350 (gp350) binding to complement receptor 2 (CR2). Despite decades of effort, no vaccines or curative agents have been developed, partly due to lack of atomic-level understanding of the virus-host interface. Here, we determined the 1.7 Å structure of gp350 in complex with CR2. CR2 binding of gp350 utilized the same set of Arg residues required for recognition of its natural ligand, complement C3d. We further determined the structures of gp350 in complex with three potently neutralizing antibodies (nAbs) obtained from vaccinated macaques and EBV-infected individuals. Like the CR2 interaction, these nAbs targeted the acidic pocket within the CR2-binding site on gp350 using Arg residues. Our results illustrate two axes of molecular mimicry-gp350 versus C3d and CR2 versus EBV nAbs-offering insights for EBV vaccines and therapeutics development.

ImmunityVol. 58(2)
Leidos (United States) (US), Henry M. Jackson Foundation (US), National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (US), Walter Reed Army Institute of Research (US)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 2%
Cytomegalovirus and herpesvirus research
10.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.